FDA Inspection
KLEB IncKLEB Inc – FDA Inspection, Dec 2, 2009
Record Details
This FDA Inspection record concerns KLEB Inc, with an inspection on December 2, 2009, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- KLEB Inc
- Inspection Date
- December 2, 2009
- Product Type
- Biologics
View Company Profile
ID · 27734562-1217-468e-9c48-27f124617e21
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 631306
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of KLEB Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 17, 2026 | Not classified | Cincinnati District Office | Human Cellular, Tissue, and Gene Therapies |
| August 24, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 7, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for KLEB Inc
- FDA Inspection 1308704 - 2026-03-17
- FDA Inspection 1216491 - 2023-08-24
- FDA Inspection 1148296 - 2021-07-28
- FDA Inspection 1040736 - 2018-02-07
- FDA Inspection 957586 - 2016-02-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.